Related Experiment Video
Updated: May 14, 2026

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
Published on: January 4, 2015
Neural stem cell-based treatment for neurodegenerative diseases
Seung U Kim1, Hong J Lee, Yun B Kim
1Medical Research Institute, Chung-Ang University College of Medicine, Seoul, Korea; Division of Neurology, Department of Medicine, UBC Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
Stem cell therapies, including those using induced pluripotent stem cells (iPSCs), show promise for treating neurodegenerative diseases by replacing lost neurons and glia. These approaches, combined with gene therapy, may offer future clinical benefits for conditions like Parkinson's and Alzheimer's.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Cell Biology
Background:
- Neurodegenerative diseases like Parkinson's, Huntington's, ALS, and Alzheimer's involve neuronal and glial cell loss.
- Stem cells (ESCs, MSCs, NSCs) can generate these crucial cell types.
- Induced pluripotent stem cells (iPSCs) from patient fibroblasts offer personalized medicine potential.
Purpose of the Study:
- To review the potential of stem cell-based therapies for neurodegenerative diseases.
- To highlight the advancements in generating neurons and glia from various stem cell sources.
- To explore the therapeutic benefits of cell and gene therapy in preclinical models.
Main Methods:
- Generation of neurons and glial cells from embryonic stem cells (ESCs), mesenchymal stem cells (MSCs), and neural stem cells (NSCs).
- Utilizing induced pluripotent stem cells (iPSCs) derived from patient fibroblasts.
- Transplantation of stem cell-derived cells into animal models of neurodegenerative diseases.
- Employing stem cell-mediated gene transfer for therapeutic gene delivery.
Main Results:
- Successful generation of functional neurons and glial cells from stem cells.
- Demonstrated clinical improvement and extended lifespan in animal models post-transplantation.
- Enhanced therapeutic effects through stem cell-mediated gene transfer of neurotrophic factors and enzymes.
Conclusions:
- Stem cell-derived cell and gene therapy holds significant potential for treating neurodegenerative diseases.
- iPSCs, ESCs, and NSCs offer promising avenues for personalized and effective treatments.
- These therapies may become standard treatments for neurodegenerative conditions, stroke, and spinal cord injuries with further research.
Related Concept Videos
Stem Cell Culture
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
iPS Cell Differentiation
Neurogenesis and Regeneration of Nervous Tissue
Induced Pluripotent Stem Cells

